Boehringer Ingelheim Investigational Site

Aurora, Colorado

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung

Studies at this site

• A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations — Completed
• Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa — Completed